Skip to main content
Research project

S Crabb: Alliance with Plexxikon: A phase Ib/IIa trial to combine the CSF1 receptor inhibitor PLX3397 with the new generation AR antagonist enzalutamide in metastatic castration resistant prostate cancer

Research areas:
Research groups:
Lead researcher:
Other researchers:
Research funder:
Plexxikon Inc
Status:
Not active
Back to top